PINK:NYE-Simplify Exchange Traded Funds - Simplify Health Care ETF (USD)

ETF | Others |

Last Closing

USD 32.97

Change

0.00 (0.00)%

Market Cap

USD 0.25B

Volume

0.12M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.03 (+0.14%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.04 (-0.07%)

USD 35.41B
DFAC Dimensional U.S. Core Equity 2..

+0.02 (+0.06%)

USD 29.38B
DTB DTE Energy Company 2020 Series

-0.01 (-0.05%)

USD 26.58B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 25.69B
JPST JPMorgan Ultra-Short Income ET..

+0.01 (+0.02%)

USD 25.59B
GBTC Grayscale Bitcoin Trust (BTC)

+1.63 (+3.53%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

+0.99 (+1.05%)

USD 13.04B
JAAA Janus Detroit Street Trust - J..

N/A

USD 11.98B
DFUV Dimensional US Marketwide Valu..

-0.01 (-0.02%)

USD 10.93B

ETFs Containing PINK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.59% 92% A 84% B
Dividend Return 0.22% 5% F 4% F
Total Return 20.81% 91% A- 82% B
Trailing 12 Months  
Capital Gain 28.39% 90% A- 83% B
Dividend Return 0.66% 11% F 7% C-
Total Return 29.05% 89% A- 80% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.19% 71% C- 54% F
Dividend Return 4.54% 68% D+ 46% F
Total Return 0.35% 19% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 8.87% 52% F 80% B-
Risk Adjusted Return 51.22% 67% D+ 69% C-
Market Capitalization 0.25B 75% C 38% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.